Deep dive · NasdaqGS: MMED
MiniMed Group, Inc. stock analysis
Everything behind the call on MiniMed Group, Inc. 6 sections, ordered the way risk stacks up: survival first, quality and price in the middle, context last. The Beacon gives you the read. This is where you check the work.
The five reads
Why the reads disagreeread this before the sections
Trend and Quality are pulling against each other and one side is clearly ahead. The net lands at +2 over 30d, a balanced reading on a dispersion of 0.22, which makes this a question of size rather than of direction.
Leans up · and why
earnings, analyst moves, sentiment vote up. 3 of 4 independent evidence families agree.
Leans down · and why
quality / value vote down. 1 of 4 families lean the other way. The conflict that matters is Trend against Quality.
What it changes
Size, not direction. dealers are long gamma, so their hedging absorbs moves rather than amplifying them; and the binding position cap is 2.6% — the tail cap is the one that binds.
Global tapeOverseas lean+0.57%
FrankfurtB8S+1.15%⏱ZurichMMED0.00%⏱
Where else this company trades. A closed venue shows its last close, marked ⏱ — not a live price. Overseas lean is the average move across the 2 overseas venues listed above, excluding the home listing — a read on overnight sentiment rather than a signal.
The bottom linestart hereAs of 2026-09-25
Wall Street rating
Buy
+25% to the average target
85% buy · 8% hold · 8% sell
median target $25
median target $25
Earnings
In 49 days
16 Nov 2026 · options imply ±12.2%
cohort P(beat) 61% · n=139,854
Valuation
31.3× forward
Against consensus earnings
FCF yield -7.49%
Dividend
0.00%
A rounding error against cash — this is a capital-gains position
Risk flags
1 critical
5 checks run, 1 clear
beta 0.72 · vol 50% ann.
worst drawdown -42%
worst drawdown -42%
New to this? Every metric carries a plain-English read beside it, and an ⓘ next to a label opens the definition. Anything unfamiliar is also defined at the foot of the page under Glossary.
NasdaqGS · USDMedical Instruments & Supplies
$19.98-0.46 · -2.25%CLOSED · vol 2.55M
52-week range↑ 88% off low · ↓ 18.2% off high
$10.65now $19.98$24.43
Quote Sep 25, 2026 · 4:00 PM ET
Tape 2026-09-25
Factors 2026-09-25
Tape 2026-09-25
Factors 2026-09-25
01Ratios · Jun 23, 2026
Survival & solvency
and 1 of 5 forensic checks clear.
↳ Plain EnglishBefore anything else: can this company pay its bills? These blocks check the balance sheet, whether your slice of ownership is being diluted, and whether the accounting looks honest.
Distance to default (Merton)
6.5σCOMFORTABLE
How many standard deviations of asset value sit between the company and its debt. Above 4σ is comfortable.
Balance sheetJun 23, 2026
1-year default probabilityEDF-CALIBRATED
0.12%
Calibrated against how often companies at this distance actually defaulted, rather than assuming a normal distribution.
Piotroski F-scoreCRITICAL
F 3/8
Piotroski F-score 3 of 8. Nine pass/fail tests covering profitability, leverage and operating efficiency; seven or more is strong.
Solvency and liquidity ratios
Current ratioshort-term assets against short-term bills1.92×healthy >2
Debt / equityborrowings against shareholder capital0.04
Net cashcash on hand in excess of every borrowing$153.00M
Your ownership stake
Share-count growth vs peersLOW DILUTION
36th pctile
Where this name's share-count growth ranks among peers. Lower is less dilutive.
Stock-based comp / revenueIN LINE
1.5%
Stock comp is the dilution pressure a buyback has to outrun. We read up to 5% of revenue as modest and above 12% as heavy — our own reading band, not a measured peer statistic.
SBC / operating cash flowFLAT
29%
How much of the cash the business generates is being handed to employees as stock. The higher it runs, the more of a buyback is just offsetting it.
Diluted vs basic share gapTHIN OVERHANG
0.00%
Options and awards already granted, expressed as the gap between the diluted and basic counts.
Accounting forensicsSEC filings
Red-flag x-rayGRADE D
50 / 100
1 critical · 2 watch · 1 clear of 4 scored tests
Red-flag x-ray · every check, passes included
CheckStatusValueWhat it looks for
Bankruptcy distressCLEARZ 3.20Altman-Z in the Safe · fundamentals
Earnings manipulationWATCHM -3.41M-score in range (m5 7/8) · fundamentals
LeverageNAn/aLong-term debt / equity not available · fundamentals
Profitability qualityCRITICALF 3/8Piotroski F-score 3 of 8 · fundamentals
Filing forensicsWATCH1 flag1 filing red flag on the latest 10-K · forensic
5 checks, 1 clear and 2 watch and 1 critical. The passes are shown because a score built from five checks means something different from one built from three.
02Refreshed · Sep 28, 2026POOR · 37/100
Business quality
-11% net margin, -9% return on equity, +14% revenue growth, and capital earning -3% against a 9% cost.
↳ Plain EnglishMargins tell you how much of each sales dollar the company keeps. Return on capital tells you whether reinvesting that money creates value. Both are read against what the filings support, not against a target.
Quality score
37 / 100POOR
Profitability, growth and balance strength scored separately, then blended.
ProfitabilityRefreshed · Sep 28, 2026
Net marginOF EVERY SALES DOLLAR
-10.7%
The share of revenue that survives every cost and becomes profit.
Gross marginPRICING POWER
54.2%
What is left of a sales dollar before overhead — the clearest read on pricing power.
Operating marginAFTER RUNNING COSTS
-5.1%
What survives the cost of running the whole business.
Return on equityPER $1 OF EQUITY
-9.2%
Annual return on each dollar of shareholder equity.
ROIC − WACC spreadDESTROYS VALUE
-11.6pp
Earns -3% on invested capital that costs about 9%. A positive spread means every retained dollar compounds rather than leaks.
Asset growth vs peersIN LINE
62nd pctile
The balance sheet grew +10% on the year. Fast asset growth is usually a ramp; occasionally it is the start of an inventory problem.
Growth & relative strength
Trailing return by period
1 month+2.4%
3 months+34.3%
6 months+38.1%
Year to date+8.1%
Revenue growth (YoY)GROWING
+14.3%
Revenue against the same period a year ago.
Relative-strength rankTOP 7%
93 / 100
Where this name's 3-month return against the S&P 500 ranks across the market — a quarter's standing, not the year's.
Around earningsSep 1, 2026
P(beat next quarter)COHORT BASE RATE
61%
survivor-tilted universe (currently-listed names; large-cap-skewed coverage)
Beat rate · this nameTRAILING
1 of 3
Its own record against consensus. 3 prints is a small sample, which is why the cohort rate above carries the probability.
Typical earnings moveData unavailableRealized move magnitudes are not published for this name yet — needs ≥8 measured prints · 3 on file.
Reaction: beat vs missData unavailableThe beat-versus-miss reaction gap is not computed for this name — undetermined — needs ≥12 measured beats.
Consensus biasVALIDATED
Persistent
insufficient surprise history
Next reportIN 49 DAYS
16 Nov 2026
Reports bmo · consensus EPS $0.12 · revenue 825.3 M
Dividends & income
Data unavailableThis company does not pay a dividend. There is no yield, payout ratio or ex-dividend date to show, and the return case rests entirely on capital gains.
Signal
Not an income position.
No dividend is declared, so nothing here contributes to total return except the price. That is a fact about the security, not a criticism of it.
Inventory ledger
Data unavailableNo inventory detail is tagged in this company's filings. The ledger needs the XBRL inventory components, which a business without physical goods does not report.
Segments & geography
Data unavailableRevenue by segment and region is not on file for this name, so product and geographic concentration are not shown.
Pattern reliability · platform-wide cohortSnapshot · Sep 28, 2026
Uptrend · leans bullish
HorizonHigherMedianObservations
10d47%-0.1%1,138,506
21d47%-0.3%534,204
63d48%-0.9%170,670
slope +0.17 over 40 bars
Three black crows · leans bearish
HorizonHigherMedianObservations
10d50%+0.1%314,318
21d50%0.0%147,650
63d49%-0.2%46,943
three falling red bars
0331.3× FORWARD
Price & timing
Price $19.98, 31.3× forward earnings, RSI 41, and dealers long gamma.
↳ Plain EnglishA multiple is what the market charges for a dollar of this company's earnings, cash or revenue; the trend and the options tape say what the price is doing around it. Together they are the timing picture, not the quality one.
Momentum (RSI-14)
41COOL
030 oversold70 hot100
Where momentum sits on a 0–100 scale. Above 70 is overbought, below 30 oversold; the middle says the move has room either way.
The setup right now
Price · 141 sessions2026-03-06 → 2026-09-25
price50-day200-day
How to read this
Down 2.25% on the session.
Follow the solid line: each point is a session close. Compare it to the 50-day average — while price stays above it the short-term trend is up, and a drop below is the first structural warning.
Typical day (ATR-14)±4.9%
$0.97
The average true range — how far this stock moves on an ordinary day. It sets the scale a stop has to clear.
MACDBELOW SIGNAL
-0.42
The short-term trend against its own signal line. The sign is the read; the size is not a target.
Bollinger position9% OF RANGE
Lower band
Where price sits inside its own volatility band. The edges are where a move is stretched, not where it reverses.
20-day VWAPPRICE BELOW
$21.97
The volume-weighted average of the last month. Price above it means recent buyers are, on average, in profit.
Chandelier exitBROKEN
$21.51
A volatility-based trailing stop, set a few average ranges below the recent high.
Pivots (classic)R1 $21 · S1 $20
$20.15
The last settled session's range projected forward. Reference levels, not predictions — after a big gap they can sit on the wrong side of the price until the next close.
16 Nov 2026 · in 49 daysNext earningsThe next scheduled catalyst. The forward guide usually moves the tape more than the printed number. Date as the vendor last stated it on 5 Sept; companies confirm about three weeks ahead, so it can still move.
2026-09-29 · tomorrowJob Openings (JOLTS)A scheduled macro release. It moves this stock independently of anything the company does.
Setup & oddsNightly
Pullback riskoverstretch read
In line1.21× segment rate · n=10,782
Historically, mid names in this tape state saw a ≥10% pullback within 63 trading days in 96% of cases (n=10,782).
Overstretchvs the 20-day mean
-1.6σ
How many standard deviations price sits from its 20-day mean. Beyond 2σ is genuinely stretched; inside it is ordinary.
Bottom zoneif it breaks down
$18 – $202 supports
Where prior demand appeared: S1 at $19.54, Pivot low at $18.85.
Slide scorefalling-knife check
0 / 100Neutral
A composite of consecutive down days, gap risk and volume expansion. Low means any decline is orderly.
Valuation
Net cash per shareCASH BACKING
$0.54
Cash less every borrowing, per share. It is the part of the price that is not a claim on future profits.
Multiples
Forward P/Eearnings expected over the next 12 months31.3×
Price / salesprice against revenue, before any of it becomes profit1.8×
Price / bookprice against the accounting value of the assets1.6×
FCF yieldfree cash flow per dollar of market value-7.49%
2 of the 4 priced multiples above sit in the richer half of its band. Each priced multiple is read against this stock's own history where a five-year range is on file, so the question is whether today is dear for this name rather than for the market. The multiples are computed separately from the quote above and are not re-priced as it moves, so they can lag it.
Price horizon & timingSep 25, 2026
Entryzone of pivot low + S1
$19.88In zone
Where the composer's entry sits, on its own stated basis.
TargetDaily pivot + round + vwap 50
$20.75$21–$21
A zone, not a price. It is where the composer expects supply, not a forecast.
Stop2× ATR below entry
$17.93risk $1.95/sh
The level that says the setup is wrong, on the basis named beside it.
Risk / rewardtarget vs stop
0.45:1flagged low
Less reward than risk at these levels. The composer publishes it rather than hiding it, because a sub-1 ratio is the argument against the trade.
Measure from a price$
To the 50-day
+0.2%
short-term trend line · $20.01
To the put wall
+50.2%
heaviest put open interest · $30.00
To the call wall
+50.2%
heaviest call open interest · $30.00
To the composer's target
+3.9%
Daily pivot + round + vwap 50 · set Sep 25, 2026 · $20.75
To the composer's stop
-10.2%
2× ATR below entry · set Sep 25, 2026 · $17.93
To the 52-week high
+22.3%
highest print of the past year · $24.43
To the 52-week low
-46.7%
lowest print of the past year · $10.65
Options-implied week ±12.2%
$17.54 – $22.42
what the chain prices for the week
A typical day (ATR)
$19.01 – $20.95
±$0.97 average true range
Type any price to re-measure every distance from it. Each row is a level this page already states somewhere else, so nothing here is a new number — and none of it is a recommendation to trade at that price.
Signal
Less reward than risk at this level.
Entry $19.88 · stop $17.93 · target $20.75, a 0.45:1 ratio. The composer flagged: fair-value reference, low reward to risk, target inside one week's move.
Gamma mapChain · Sep 28, 2026
Signal
Long gamma — moves get absorbed.
Dealers hedge against the move, which damps volatility around the current strikes. It makes the tape quieter without saying anything about which way it goes.
Options tapeFront expiry 2026-10-16 · Chain · Sep 28, 2026
Max pain+50.2%
$30.00
The strike where most open options expire worthless. Price often drifts toward it into expiry.
Put / call ratio (OI)CALL-HEAVY
0.99
50% calls
50% puts
Open interest in puts against calls. Heavy call interest often caps how far price can run before expiry.
Put / call ratio (volume)TODAY'S FLOW
1.07
Today's traded flow rather than the standing position. It moves faster and means less.
Expected move (1-week)≈ $2.44
±12.2%
What the chain prices for the week. A range the market is charging for, not a forecast.
Largest open interest · front expiry
StrikeTypeOpen interest
$30.00CALL5,521
$30.00PUT5,520
$25.00PUT4,156
$25.00CALL2,600
$22.50CALL2,382
$15.00PUT336
Large call interest above the price acts as a magnet and a ceiling; large put interest below is a floor of hedges. The biggest strike is the level the market is most committed to defending into the next expiry.
Open interest by strikeexpires 2026-10-16CallsPutsMax pain $30.00
0
$40.00
10
$35.00
106k
$30.00
6k3k
$25.00
4k2k
$22.50
11625
$20.00
2692
$17.50
210
$15.00
3362
$12.50
141
$10.00
2
The shaded row is the strike nearest the price. Heavy call interest above acts as a ceiling; heavy put interest below is a floor of hedges.
↑ 52-week high$24.43+22.3%The highest print of the past year.Old highs draw profit-taking on the first attempt.
↑ Call wall$30.00+50.2%Heaviest call open interest on the front expiry.Acts as a ceiling into expiry; a close above usually needs a catalyst.
◇ Max pain$30.00+50.2%Where most open options expire worthless.Price often drifts toward it into the close of the expiry week.
↓ 50-day average$20.01+0.2%The line the short-term trend is measured against.A close beneath it is the first structural warning.
↓ Put wall$30.00+50.2%Heaviest put open interest — a floor of hedges.Dealer buying tends to build as price approaches.
0413F quarterly · Form 4 dailyNET SIGNAL +2
Ownership & flow
Institutions hold 14%, short interest is 48.55% of float, and 13 analysts average $25.
↳ Plain EnglishWho is buying and selling, and what they had to disclose. Institutions file 13F 45 days after quarter end, executives file Form 4 within two days, and Congress discloses under the STOCK Act with a 30–45 day legal lag. Every one of those is a look backwards.
Net signal
+2BALANCED · 30d
3 bull / 1 bear factors. The points sum to the net beside the label; nothing here is weighted after the fact.
The QTick signalNightly
Analyst moves90D · TIMING
+1
8 price-target raises in 90d
Earnings4 QUARTERS · TIMING
+2
latest EPS beat by 38%
Quality / valueTTM · CONTEXT
-2
weak Piotroski F-score (3/8)
Sentiment1–30D · TIMING
+1
7d sentiment elevated (83/100)
Signal
3 bull / 1 bear factors
Independent factors scored and netted to +2 over 30d, a balanced reading. 4 of 9 factors carried a direction; the others scored zero and do not vote. The signal describes where the data leans, not what to do about it.
Cross-category readSep 27, 2026
Signal
3 of 4 families lean up.
Descriptive only — a decorrelated read of where the evidence agrees and conflicts, not a forecast and not advice. Patterns are condition lists, not outcome predictions, and are not yet validated to the proof bar. Dispersion of 0.22 means the disagreement is real but not a split decision.
Wall Street13 covering firms
Consensus rating13 ANALYSTS
Buy
85% buy · 8% hold · 8% sell, as a share of the 13 covering firms.
Median price target+25%
$25
$15now $20$29
A $15–$29 spread across the panel. A twelve-month view, and a wide spread means real disagreement rather than a consensus.
Forward EPS estimateCONSENSUS
$0.64
What the panel expects the company to earn per share.
Recent analyst moves · last 90 days
FirmTargetDirectionRank
Truist Securities$29↑51/100
Morgan Stanley$21↑51/100
Citigroup$26↑53/100
Evercore ISI Group$27↑52/100
Wells Fargo$26↑52/100
UBS$28↑52/100
Mizuho$26↑51/100
B of A Securities$28↑52/100
Upgrades, downgrades and target changes from covering firms. A cluster of moves in one direction matters more than any single target; the rank is the firm's own credibility score, or a dash below the scoring floor.
Who owns it13F quarterly · Form 4 daily
Institutional ownershipRETAIL-HEAVY
13.5%
The share held by 13F filers. It describes last quarter's positioning, not today's — filings land up to 45 days after quarter end.
Insider ownershipOFFICERS & DIRECTORS
89.9%
The share held by the people running the company.
Short interest (float)CROWDED
48.55%
Rising — shares short changed +130.6% over 30 days. A crowded short is fuel in both directions.
Free float10% OF SHARES
28.00M
Shares actually available to trade, excluding insider and restricted holdings.
Dollar volume (ADV)76th PCTILE
$32.91M/day
Average dollars traded per day, and where that ranks cross-sectionally. Thin liquidity is a cost you pay on the way out, not just on the way in.
Borrow feeData unavailableWe do not license securities-lending data, so the annualized cost of borrowing shares to short is not something we can show. Short interest and days-to-cover above are the closest read we can source.
Insider filings · Form 4
InsiderTradeAmountPlanTraded
Dianaty Ali · EVP Ch. Prod. & Tech OfficerTax withholding$145,418—31 Jul
Wills Courtney Nelson · SVP, Gen. Counsel, Corp. Sec.Tax withholding$31,980—31 Jul
Dallara Que · Director, Chief Executive OfficerTax withholding$569,002—31 Jul
Chandrasena Gillian · SVP, Chief HR OfficerTax withholding$37,089—28 Jul
Spooner Chad · EVP, Chief Financial OfficerTax withholding$411,729—28 Jul
Chandrasena Gillian · SVP, Chief HR OfficerAwardnot on file—01 Jul
Executives must file within two business days. Sales on pre-set 10b5-1 plans are scheduled months ahead and carry little signal; tax withholding, exercises and awards are compensation mechanics, not trades; the open-market lines are the ones to read.
The story · news & sentimentRolling window
Why it moved todayNEWS
-2.25%
MMED fell −2.25% since the last close, amid recent coverage: “MiniMed Group Stock Short Interest Rises to 47.64% - Quiver Quantitative” (Quiver Quantitative).
News tone · 7-day—
83 / 100
Headline polarity over the window, scored from news articles. Above 60 leans positive, below 40 negative. Colour, not a signal.
Newswire · 49 stories
WhenHeadlineSourceTone
SatMiniMed Group Inc $MMED Shares Newly Acquired by State Street Corp - MarketBeatMarketBeatnot scored
FriMiniMed Group Stock Short Interest Rises to 47.64% - Quiver QuantitativeQuiver Quantitativenot scored
ThuMiniMed a new Buy at Truist on turnaround following Medtronic split - Seeking AlphaSeeking Alphanot scored
ThuMiniMed Group (NASDAQ:MMED) Coverage Initiated at Truist Financial - MarketBeatMarketBeatnot scored
ThuTruist initiates MiniMed Group stock at Buy on diabetes product cycle - Investing.comInvesting.comnot scored
ThuTruist initiates MiniMed Group stock at Buy on diabetes product cycle - Investing.com UKInvesting.com UKnot scored
WedMMED: Accelerating innovation and global scale drive durable growth, with Vivera set to transform diabetes care - TradingViewTradingViewnot scored
WedMMED: Accelerated innovation, global scale, and a unique algorithm drive durable growth and profitability - TradingViewTradingViewnot scored
Coverage published around the move, newest first. Nothing here measures causation — only the why-it-moved card above is matched to the tape by timestamp.
Congress
Data unavailableNo congressional trades in this name have been disclosed under the STOCK Act. Lawmakers' disclosed trades cluster heavily in large caps, so an empty list is the usual state.
0511 graded callsHIGH VOLATILITY
Risk & track record
Beta 0.72, 50% annual volatility, a -42% worst drawdown, and 2 of 8 risk surfaces clear.
↳ Plain EnglishWhat owning it does to a portfolio, what the model votes against, and how often our own calls have been right. Every call is graded when it resolves, and the ones still open stay visible.
Max drawdown
-41.6%WORST FALL
The deepest peak-to-trough fall in the measured window. Only hold a position you can watch do this.
What it does to a portfolio5-year window
Beta (vs the market)LOW FIT
0.72
The market explains about 2.9% of its daily moves, so this beta says little about how it tracks the index — most of its movement is its own.
Annualized volatilityELEVATED
50%
How far it swings over a year, from its own realized returns.
Tactical phaseNIGHTLY READ
Neutral
Selling pressure22
Buying pressure14
Overheat0
State: neutral — No dominant short-horizon pressure in the tape.
What votes againstNightly
MedQuality / valueweak Piotroski F-score (3/8)TTM · -2
Signal
1 of 9 factors vote against.
Ranked by the size of each factor's own point contribution to the net signal — these are the model's stated reasons, not a written bear case. Each one is scored from the source named beside it.
Failure modes · by company type
Data unavailableFailure modes are routed per company type, and only the bank-run and crypto-treasury rulebooks are validated so far. This name routes as growth, so there is no cohort-specific checklist to run. A generic list would read as analysis without being any.
The risk case · why not to buy8 surfaces · nightly
Suggested position capmax defensible size
2.6%tail cap binds
max defensible size 2.6% - tail binds
Avoid score6-month distress
6.5%0.7× its cohort · most-traded mega-caps
Observational 6-month large-drawdown risk ranking — not a forecast, not alpha. Historical distress rate for this most-traded mega-caps segment: 9.3%. This name reads 0.7× that base rate.
LowDistress screenThe distress model did not score this name in the latest run, so this surface is unmeasured rather than clear.Not scored
MedPosition size, not conviction, is the binding constrainthalf-Kelly 28.1% · tail cap 2.6% · category cap 54.6%. The tail cap binds, so 2.6% is the number (n=120,445). We show which one binds rather than the friendliest.Sizing
MedLottery-ticket behaviourIts best 21-day return sits at 10.7% against a 9.6% cohort 90th-percentile threshold — above the line where forward returns have historically turned negative.Behaviour
HighCash runwayAbout 2.8 quarters of cash at current burn ($298M cash against $420M a year of burn) - names in this bucket: 26.8% catastrophe rate within a year.Solvency
LowPost-earnings driftDrift odds at full strength (+2.24% / 63-day spread reference from measured post-earnings drift).Timing
LowDividend riskNot scored for this name.Not scored
LowRestatement historyFiling history is not deep enough to check for restatements.Not scored
LowCrowded shortNot in a warn state: the crowded-short model only publishes when short interest and thin liquidity coincide, and neither condition is met here.Not scored
Signal
2 of 8 surfaces clear.
8 surfaces checked, 2 clear. The binding constraint is position size — the tail cap is the one that binds. Each row states which surface it is and what it measured; a surface that could not be scored says so rather than counting as clear.
Who should skip it
Skip it if any of these is you
You can't sit through -42%
That is this name's deepest measured fall, on 50% annualized volatility. A drawdown of that size is normal here, not exceptional.
You want income
A 0.00% yield is a rounding error against cash. This is a capital-gains position.
You'd size it like a core holding
The binding cap is 2.6% of a portfolio. Above that the tail stops being survivable.
Our track record11 resolved
Track recordBUILDING IN THE OPEN
24 logged
24 calls logged on this name, 11 resolved so far. Calls are logged the moment they are made, so the open ones are public before anyone knows how they turn out, and a hit-rate is not published until enough of them resolve.
Calls on MMEDTHIS NAME
24
This name's own call count. Too few have resolved to publish a rate over them, so none is shown rather than a rate over 11.
0610-K disclosed linksMEDICAL INSTRUMENTS & SUPPLIES
The wider context
5 mapped peers, 3 connections.
↳ Plain EnglishCompanies do not trade alone. This is the peer set, the supply chain that has to deliver, and the macro variables that move the stock regardless of company news.
Next macro catalyst
Job Openings (JOLTS)TOMORROW
2026-09-29. A scheduled release that moves this stock independently of anything the company does.
Versus peersLatest session
Peer set · 5 names
SymbolRelationshipPriceSession
ISRGPeer$405.18+1.42%
MDLNPeer$34.70+0.12%
BDXPeer$183.82+2.56%
ALCPeer$64.47-0.14%
RMDPeer$222.00+0.05%
The mapped peer set and how each traded in the latest session. A peer moving with this name says the move is the sector's; one moving against it says the move is this company's.
Time machineHistory from 2026-03-06
Signal
Every backward window is positive.
That is the definition of a stock that has already worked, and it says nothing about the next window. What it does tell you is what a drawdown would be measured against.
Macro driversRolling window
Events · what moves this stockSep 20, 2026
Initial jobless claimsLittle effect either way
Healthcare demand does not depend on hiring.
Typical for the Healthcare sector
On the day +0.4% · A week later +2.1% · Two weeks later +4.4% · Rose on 14 of 25 report days
Across the last 25 Initial jobless claims reports since Mar 19, 2026, MMED moved +0.4% on average on the day and was 4.4% higher two weeks later. The S&P 500 moved +0.2% on those days.
Government shutdown / funding deadlineUsually hurts when funding lapses and the government shuts down
Medicaid and other federal payments are delayed.
Typical for the Healthcare sector
No price history on file yet for MMED around this report. The read above is for its sector as a whole.
Core PCE (the Fed's gauge) is due in 2 days.
Core PCE (the Fed's gauge)Little effect either wayPeople need care regardless of prices; healthcare barely reacts to the print itself.
Typical for the Healthcare sector
On the day +3.4% · A week later +6.8% · Two weeks later +10.9% · Rose on 6 of 6 report days
Only 6 reports on file, so treat this as a sketch, not a pattern. Across the last 6 Core PCE (the Fed's gauge) reports since Mar 31, 2026, MMED moved +3.4% on average on the day and was 10.9% higher two weeks later. The S&P 500 moved +0.4% on those days.
Core inflation (core CPI)Little effect either way
People need care regardless of prices; healthcare barely reacts to the print itself.
Typical for the Healthcare sector
On the day +1.1% · A week later +1.7% · Two weeks later -1.5% · Rose on 4 of 6 report days
Only 6 reports on file, so treat this as a sketch, not a pattern. Across the last 6 Core inflation (core CPI) reports since Mar 15, 2026, MMED moved +1.1% on average on the day and was 1.5% lower two weeks later. The S&P 500 moved +0.4% on those days.
FOMC decisionLittle effect either way
Healthcare demand does not depend on rates.
Typical for the Healthcare sector
On the day +0.6% · A week later +6.1% · Two weeks later +7.5% · Rose on 3 of 6 report days
Only 6 reports on file, so treat this as a sketch, not a pattern. Across the last 6 FOMC decision reports since Mar 31, 2026, MMED moved +0.6% on average on the day and was 7.5% higher two weeks later. The S&P 500 moved +0.6% on those days.
On the day -0.9% · A week later -3.2% · Two weeks later +3.1% · Rose on 2 of 6 report days
Only 6 reports on file, so treat this as a sketch, not a pattern. Across the last 6 Housing starts reports since Mar 23, 2026, MMED moved -0.9% on average on the day and was 3.1% higher two weeks later. The S&P 500 moved +0.1% on those days.
Industrial productionLittle effect either way
Healthcare does not track the business cycle.
Typical for the Healthcare sector
On the day -0.1% · A week later -3.2% · Two weeks later -0.7% · Rose on 3 of 6 report days
Only 6 reports on file, so treat this as a sketch, not a pattern. Across the last 6 Industrial production reports since Mar 18, 2026, MMED moved -0.1% on average on the day and was 0.7% lower two weeks later. The S&P 500 moved 0.0% on those days.
Inflation (CPI)Little effect either way
People need care regardless of prices; healthcare barely reacts to the print itself.
Typical for the Healthcare sector
On the day +1.1% · A week later +1.7% · Two weeks later -1.5% · Rose on 4 of 6 report days
Only 6 reports on file, so treat this as a sketch, not a pattern. Across the last 6 Inflation (CPI) reports since Mar 15, 2026, MMED moved +1.1% on average on the day and was 1.5% lower two weeks later. The S&P 500 moved +0.4% on those days.
Customer momentum
Data unavailableCustomer momentum needs listed customers that disclose a revenue dependence on this company, and none is on file. The connections below are a different map: competitors and partners, most of them curated rather than filed.
Connections3 links · none confirmed
Direct connections · 3 edges
CompanyRelationSessionProvenance
IQV · Partnerpartner-1.69%Rumored · manual
AMZN · Suppliersupplier+0.12%Rumored · manual
PFE · Competitorcompetitor+0.92%Rumored · manual
0 of 3 edges are named in a filing; the rest come from reporting we have not matched to one yet, and are labelled as such.
Glossary · every term on this page
Survival
Altman Z
Bankruptcy-risk score. Above 3.0 is the safe band.
Piotroski F
Nine pass/fail health tests; 7 or more is strong.
Beneish M
Accrual and growth pattern screen. Clear below −2.22, watch to −1.78, elevated above; a year of very fast revenue growth lifts it by construction.
Merton DTD
Standard deviations of asset value between the company and its debt.
EDF
Default frequency calibrated on what actually happened to similar names.
Price & tape
RSI-14
Momentum gauge 0–100. Above 70 is overbought, below 30 oversold.
ATR
Average true range — the size of a typical day.
VWAP
20-day volume-weighted average price — the average paid over the last month; the page shows no intraday VWAP.
Supertrend
A trend-following stop line. A close through it flips the read.
Chandelier
A trailing stop set a few average ranges below the recent high.
Options & flow
Gamma / GEX
Dealer hedging pressure. Negative gamma amplifies moves both ways.
Call / put wall
The strikes with the heaviest open interest; they act as ceiling and floor.
Max pain
The strike where most options expire worthless.
13F · Form 4
Institutional filings, 45 days after quarter end. Insider trades, within two days.
Scoring
Composite signal
Independent factors scored and netted into one number.
Hit-rate
Share of past calls that resolved in the direction stated.
Brier score
Calibration measure. Lower means stated probabilities track reality.
HHI
Concentration 0–10,000. Above 2,500 means one segment carries the company.
EVT
Fits the tail rather than assuming a bell curve, so bad days are not understated.